N L Rasgon

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Estrogen use and brain metabolic change in older adults. A preliminary report
    N L Rasgon
    Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, The Neuropsychiatric Institute, Los Angeles, CA 90095, USA
    Psychiatry Res 107:11-8. 2001
  2. ncbi Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review
    N L Rasgon
    Curr Drug Targets Immune Endocr Metabol Disord 2:97-102. 2002
  3. ncbi Depression in women with polycystic ovary syndrome: clinical and biochemical correlates
    Natalie L Rasgon
    Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles School of Medicine, Mood Disorders Research Program, 300 Medical Plaza, Suite 1544, Los Angeles, CA 90095 7057, USA
    J Affect Disord 74:299-304. 2003
  4. pmc Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
    G W Small
    Center on Aging and Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Proc Natl Acad Sci U S A 97:6037-42. 2000
  5. ncbi Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder
    R A Suri
    Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, USA
    J Clin Psychiatry 61:942-6. 2000
  6. ncbi Mood and neuropsychological changes in women with midlife depression treated with escitalopram
    Tonita E Wroolie
    Behavioral Neuroendocrinology Program, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Psychopharmacol 26:361-6. 2006
  7. ncbi Longitudinal evaluation of reproductive function in women treated for bipolar disorder
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Stanford University, 401 Quarry Road, Palo Alto, Ca 94305 5723 Stanford, California, United States
    J Affect Disord 89:217-25. 2005
  8. ncbi Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, 401 Quarry Road, Room 2360, Palo Alto, CA 94305 5723, USA
    Psychoneuroendocrinology 30:558-67. 2005
  9. ncbi Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women
    Natalie L Rasgon
    Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles, USA
    J Clin Psychiatry 63:45-8. 2002
  10. ncbi Mood symptoms and cognitive performance in women estrogen users and nonusers and men
    Karen J Miller
    Department of Psychiatry and Biobehavioral Sciences, The Neuropsychiatric Institute, University of California, Los Angeles, CA 90024, USA
    J Am Geriatr Soc 50:1826-30. 2002

Detail Information

Publications18

  1. ncbi Estrogen use and brain metabolic change in older adults. A preliminary report
    N L Rasgon
    Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, The Neuropsychiatric Institute, Los Angeles, CA 90095, USA
    Psychiatry Res 107:11-8. 2001
    ..These findings suggest that estrogen use may protect against regional cerebral metabolic decline in postmenopausal women...
  2. ncbi Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review
    N L Rasgon
    Curr Drug Targets Immune Endocr Metabol Disord 2:97-102. 2002
    ..We suggest that through treatment of underlying metabolic defects, both the mood of the patient and the metabolic condition of PCOS can be assisted...
  3. ncbi Depression in women with polycystic ovary syndrome: clinical and biochemical correlates
    Natalie L Rasgon
    Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles School of Medicine, Mood Disorders Research Program, 300 Medical Plaza, Suite 1544, Los Angeles, CA 90095 7057, USA
    J Affect Disord 74:299-304. 2003
    ..We assessed the prevalence of mood disturbance among women with prospectively documented polycystic ovary syndrome (PCOS)...
  4. pmc Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
    G W Small
    Center on Aging and Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Proc Natl Acad Sci U S A 97:6037-42. 2000
    ..These results indicate that the combination of cerebral metabolic rates and genetic risk factors provides a means for preclinical AD detection that will assist in response monitoring during experimental treatments...
  5. ncbi Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder
    R A Suri
    Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, USA
    J Clin Psychiatry 61:942-6. 2000
    ..Few studies have compared the treatment efficacy of the 2 selective serotonin reuptake inhibitors sertraline and fluoxetine...
  6. ncbi Mood and neuropsychological changes in women with midlife depression treated with escitalopram
    Tonita E Wroolie
    Behavioral Neuroendocrinology Program, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Psychopharmacol 26:361-6. 2006
    ..This study assessed mood and neuropsychological function in a population of middle-aged women with major depressive disorder treated with escitalopram...
  7. ncbi Longitudinal evaluation of reproductive function in women treated for bipolar disorder
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Stanford University, 401 Quarry Road, Palo Alto, Ca 94305 5723 Stanford, California, United States
    J Affect Disord 89:217-25. 2005
    ..We assessed reproductive endocrine and metabolic markers in women treated for bipolar disorder over a 2-year time period, controlling for valproate use...
  8. ncbi Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, 401 Quarry Road, Room 2360, Palo Alto, CA 94305 5723, USA
    Psychoneuroendocrinology 30:558-67. 2005
    ..To analyze the risk of cognitive impairment among female Swedish Twins with regard to endogenous and exogenous hormone exposure...
  9. ncbi Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women
    Natalie L Rasgon
    Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles, USA
    J Clin Psychiatry 63:45-8. 2002
    ..Fluctuating estrogen levels accompany the perimenopausal transition. Thus, estrogen replacement therapy (ERT) has been proposed as a potentially effective treatment for mood disorders occurring during perimenopause...
  10. ncbi Mood symptoms and cognitive performance in women estrogen users and nonusers and men
    Karen J Miller
    Department of Psychiatry and Biobehavioral Sciences, The Neuropsychiatric Institute, University of California, Los Angeles, CA 90024, USA
    J Am Geriatr Soc 50:1826-30. 2002
    ..In this study, we explore sex differences for a range of mood symptoms and for neuropsychological performance in men and postmenopausal women and assess the potential influence of estrogen on these measures...
  11. ncbi Estrogen use and brain metabolic change in postmenopausal women
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
    Neurobiol Aging 26:229-35. 2005
    ..We used positron emission tomography to evaluate cerebral glucose metabolic change in postmenopausal women in a naturalistic observational study...
  12. ncbi Self-reported data from patients with bipolar disorder: frequency of brief depression
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Germany
    J Affect Disord 101:227-33. 2007
    ..Using daily self-reported mood ratings, we studied how changing the length requirement to that typical of recurrent brief depression (2-4 days) would impact the number of depressed episodes...
  13. ncbi Self-reported data from patients with bipolar disorder: impact on minimum episode length for hypomania
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charité Mitte CCM, Schumannstr 20 21, 10117 Berlin, Germany
    J Affect Disord 96:101-5. 2006
    ..Using daily self-reported mood ratings, we studied the impact of changing the length requirement on the number of hypomanic episodes in patients with bipolar disorder...
  14. ncbi Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study
    Natalie L Rasgon
    Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, 410 Quarry Road, Room 2368, Palo Alto, CA 94305 5723, USA
    J Psychiatr Res 41:338-43. 2007
    ..Pilot study examining the effects of estrogen therapy (ET) on antidepressant response in postmenopausal women with major depressive disorder (MDD)...
  15. ncbi Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5723, USA
    Neurobiol Aging 26:103-7. 2005
    ..Herein, we review the IR link in depressive disorders and AD and describe the results of our studies and others in support of this hypothesis...
  16. ncbi Reproductive function and risk for PCOS in women treated for bipolar disorder
    Natalie L Rasgon
    Department of Psychiatry, Stanford School of Medicine, Palo Alto, CA, USA
    Bipolar Disord 7:246-59. 2005
    ..This study examined the reproductive function and prevalence of polycystic ovary syndrome (PCOS) in women with bipolar disorder taking antimanic medications...
  17. ncbi Emergent oscillations in a mathematical model of the human menstrual cycle
    Natalie L Rasgon
    Department of Psychiatry and Biobehavioral Sciences, Stanford School of Medicine, Palo Alto, California 94305, USA
    CNS Spectr 8:805-14. 2003
    ..The aim of this study was to develop a mathematical model of the hypothalamo-pituitary-gonadal axis that would reflect available data in humans...
  18. ncbi Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report
    Wendy K Marsh
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, United States
    J Psychiatr Res 42:247-51. 2008
    ..The menopausal transition in women without mood disorders is associated with an increase in depression. This study assesses mood course during the menopausal transition in women with bipolar disorder...